Vernice Bates is a Neurology physician affiliated with Dent Neurologic Institute. OpenAlex indexes 162 publications with 12,207 citations (h-index 55); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3980a Sheridan Dr
Amherst, NY 142261727
Telephone
716-250-2000Registry record last updated 14 Feb 2017.
Clinical trials
- Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant
Sponsor: Dent Neuroscience Research Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year20256 payments
- Teva Pharmaceuticals USA, Inc.Program year20253 payments
- Eisai Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
76.9%Other antiepileptics34.1%Levetiracetam58%Topiramate42%Part D<11 patientsGabapentinoids27.5%Gabapentin100%Part D≥11 patients+ 1 more class in this area
Blood & clotting
23.1%P2Y12 inhibitor23.1%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Anatomically interpretable deep learning of brain age captures domain-specific cognitive impairment
Proceedings of the National Academy of Sciences
2023 - Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction
Communications Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Horacio Capote, MD
Dent Neurologic Institute
Laszlo Mechtler, MD
Dent Neurologic Institute
Jennifer McVige, MD
Dent Neurologic Institute
Tomas Holmlund, MD
Dent Neurologic Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”